Abstract

In 2013, the American Medical Association (AMA) decided to recognize obesity as a disease. One of the main arguments presented in favor of this was broadly ‘utilitarian’: the disease label would, it was claimed, provide more benefits than harms and thereby serve the general good. Several individuals and groups have argued that this reasoning is just as powerful in the European context. Drawing mainly on a review of relevant social science research, we discuss the validity of this argument. Our conclusion is that in a Western European welfare state, defining obesity as a disease will not on balance serve the general good, and that it is therefore more appropriate to continue to treat obesity as a risk factor. The main reasons presented in favor of this conclusion are: It is debatable whether a disease label would lead to better access to care and preventive measures and provide better legal protection in Europe. Medicalization and overtreatment are possible negative effects of a disease label. There is no evidence to support the claim that declaring obesity a disease would reduce discrimination or stigmatization. In fact, the contrary is more likely, since a disease label would categorically define the obese body as deviant.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Clinical Nutrition
Vol/bind71
Sider (fra-til)1263–1267
Antal sider5
ISSN0954-3007
DOI
StatusUdgivet - 2017

Emneord

  • Det Sundhedsvidenskabelige Fakultet
  • obesity
  • disease
  • stigma
  • utilitarian argument
  • medicalisation

Citationsformater